Bridgeway Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.84M Sell
66,100
-15,000
-18% -$645K 0.06% 415
2025
Q4
$3.55M Sell
81,100
-550
-0.7% -$22.8K 0.07% 332
2025
Q3
$3.37M Buy
81,650
+16,950
+26% +$681K 0.07% 365
2025
Q2
$2.85M Sell
64,700
-3,300
-5% -$132K 0.07% 398
2025
Q1
$2.51M Hold
68,000
0.06% 425
2024
Q4
$2.26M Buy
+68,000
New +$2.21M 0.05% 490

Other funds holding EXEL

Bridgeway Capital Management's EXEL Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Exelixis (EXEL) stake by 18% in Q1 2026, selling an estimated $645K and leaving 66,100 shares worth $2.84M. The position accounts for 0.06% of the portfolio, ranked #415.

Bridgeway Capital Management first reported a position in EXEL in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.55M in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Bridgeway Capital Management held 66,100 shares of Exelixis worth $2.84M as of Q1 2026.
  • Bridgeway Capital Management sold 15,000 Exelixis shares in Q1 2026, an estimated $645K.
  • Exelixis made up 0.06% of Bridgeway Capital Management's portfolio in Q1 2026, its #415 holding.
  • Bridgeway Capital Management first reported a position in Exelixis in Q4 2024 and has held it in 6 quarters since.
  • Bridgeway Capital Management's Exelixis position peaked at $3.55M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.